Lupin posts Q2 results

October 30, 2014 | Thursday | News | By BioSpectrum Bureau

Lupin posts Q2 2014 outcome

(Photo Courtesy: www.fiercehealthfinance.com)

(Photo Courtesy: www.fiercehealthfinance.com)

Lupin Ltd has announced the following results on Bombay Stock Exchange for the quarter ended September 30, 2014:

The Unaudited Standalone results for the Quarter ended September 30, 2014

The Company has posted a net profit of Rs. 4596.20 million for the quarter ended September 30, 2014 as compared to Rs. 8091.20 million for the quarter ended September 30, 2013. Total Income has decreased from Rs. 25414.80 million for the quarter ended September 30, 2013 to Rs. 23478.30 million for the quarter ended September 30, 2014.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended September 30, 2014

The Group has posted a profit after taxes and minority interest of Rs. 6300.40 million for the quarter ended September 30, 2014 as compared to Rs. 4061.80 million for the quarter ended September 30, 2013. Total Income has increased from Rs. 27492.30 million for the quarter ended September 30, 2013 to Rs. 32836.40 million for the quarter ended September 30, 2014.

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy